Taros EVP Youri R. Mesmoudi was interviewed in the current Issue of CHEManager´s Section Chemistry & Life Sciences on “From Idea to Product – the principle of an extended workbench accelerates innovation in chemistry”
Due to current situation with the spread of the Sars-CoV-2 (“Coronavirus”) we want to share with you the latest information on how Taros Chemicals have prepared for both, the protection of our employees and partners’ health and the uninterrupted continuation of our chemistry and discovery services to our clients…
electBIO Organ-on-a-Chip, Tissue-on-a-Chip & Organoids Europe 2020 focuses on an important and expanding field wherein cells are being assembled using Microfluidics and Lab-on-a-Chip technologies in a functionally-relevant manner. These clusters of “assembled cells” have…
Ahead of Oxford Global’s R&D Series Drug Discovery Summit on 26-27 May 2019 in Berlin, Germany, Oxford Global spoke to Torsten Hoffmann of Taros Chemicals about his work in Pharmaceutical R&D and the opportunities and challenges in Drug Discovery…
We are transforming your ideas into products
We provide long-term added value to our diverse customers through cutting-edge and innovative chemistry-based technologies
Taros creates holistic and cost-effective solutions of the highest quality and reliability for the global marketplace. We are inspired to provide exceptional added value to our customers’ R&D processes by anticipating hurdles foreseeing cost and lead time reductions. tThereby we facilitate competitive and “early-to-market” advantages. With our state-of-the-art lab facilities and our scientists (of which 65% hold a Ph.D. in Chemistry), we are committed to serve the diverse needs of our customers in drug discovery, custom synthesis and specialty or performance chemicals. More than 13,000 synthesis, research and process chemistry projects have been delivered successfully to our ever-growing global customer base.